Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Celecoxib 200mg Capsule – PA0711/241/002
- Deslor 0.5mg/ml Oral Solution – PA0711/202/002
- Estradot 37.5mcg/day Transdermal Patch – PA0896/010/001
- Gaviscon Advance Oral Suspension – PA0979/011/001
- Gaviscon Liquid Peppermint Flavour Oral Suspension – PA0979/015/002
- Lipantil 145mg Film Coated Tablet – PA2010/015/003
- Lyrica 75mg Capsule – EU/1/04/279/012
- Stilnoct 5mg Tablet – PA0540/160/001
- TOBI 300mg/5ml Nebuliser Solution – PA2010/063/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Amisulpride 200mg Tablet – PA0577/182/002
- Colofac 135mg Tablet – PA2010/007/001
- Neurontin 600mg Capsule – PA0822/015/004
- Septrin Forte 160mg/800mg Tablet – PA1691/010/002
- Valdoxan 25mg Tablet – EU/1/08/499/003
- Vancomycin 500mg Powder for Concentration for Solution for Infusion & Oral Solution – PA1122/008/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.